2022•Hepatoma ResearchOpen access

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Andrew J. Woerner, Guy E. Johnson

Abstract

Hepatocellular carcinoma remains a prominent cause of cancer-related mortality globally. Transarterial yttrium-90 radioembolization is a versatile therapy and plays an important role in the treatment of hepatocellular carcinoma. This review summarizes the establishment of radioembolization in the hepatocellular carcinoma treatment paradigm, treatment considerations across cancer stages, and recent advances in evidence.

Open-access reader

About this research paper

What this paper is about

Why it matters

OpenAlex reports 12 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Hepatocellular carcinoma, Medicine, Curative treatment, Carcinoma, Radiology, Oncology, Internal medicine, Disease